Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

RNA Therapy Helps Reduce Preeclampsia Symptoms

Pregnant woman

Experimental treatments with engineered RNA are shown in lab animals to reduce symptoms of preeclampsia, a disorder causing high blood pressure in pregnant women. . . . → Read More: RNA Therapy Helps Reduce Preeclampsia Symptoms

Trial Shows Treatment Prevents Peanut Allergy Reactions

Peanutes in shells

Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year. . . . → Read More: Trial Shows Treatment Prevents Peanut Allergy Reactions

Faster Crop Breeding Techniques Made Available to Other Scientists

Growing wheat

Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties. . . . → Read More: Faster Crop Breeding Techniques Made Available to Other Scientists

DNA-Encoded Synthetic Antibodies Protect Against Ebola

Ebola virus

Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses. . . . → Read More: DNA-Encoded Synthetic Antibodies Protect Against Ebola

Biotechs to Develop Personal Cancer-Killing Virus Vaccines

Adenovirus illustration

Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. . . . → Read More: Biotechs to Develop Personal Cancer-Killing Virus Vaccines

RNA Therapeutics Company Raises $30M in First Venture Round

Kevin Weeks

A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round

Nanotech Immunotherapy Reduces Heart Transplant Rejection

Heart and major blood vessels

Proteins known to regulate immune cells, given as nanoscale particles, are shown in lab mice to encourage long-term acceptance of a transplanted heart. . . . → Read More: Nanotech Immunotherapy Reduces Heart Transplant Rejection

New Processes Devised to Boost Antibiotics

MRSA bacteria

Researchers in chemistry at two institutions report new techniques that lab tests show modify current antibiotics to make them more effective against infections that resist today’s antibiotics. . . . → Read More: New Processes Devised to Boost Antibiotics

Synthetic DNA Company Raising $70 Million in IPO

NASDAQ share price display

A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering. . . . → Read More: Synthetic DNA Company Raising $70 Million in IPO

FDA Preparing Animal, Plant Biotech Regulatory Guidance

Two piglets

The Food and Drug Administration intends to issue new regulatory guidance to cover advances in biotechnology, including genome editing, in animals and plants. . . . → Read More: FDA Preparing Animal, Plant Biotech Regulatory Guidance